AGILE, EU Defence, Defence Innovation, SMEs,

AGILE EU Defence Funding 2027: Eligibility, IP and Ukraine

EU approves €115m AGILE defence funding. CORVUS AI examines SME eligibility, Ukraine's participation, IP rights, export controls and 2027 calls.

Complex law. Clear action.

Reviewed by Oleksandr Sobovyi, Founder & CEO of CORVUS AI — editorial responsibility statement below.

On 12 October 2026, the Council of the European Union formally adopted the Regulation establishing the Programme for Agile and Rapid Defence Innovation (AGILE), a new €115 million instrument designed to accelerate the development and deployment of innovative defence technologies.

The European Parliament approved the legislation on 6 October 2026, following a political agreement reached on 15 July.

AGILE targets small and medium-sized enterprises (SMEs), including start-ups and scale-ups, developing emerging and disruptive defence products. Its objective is to shorten the distance between technological innovation and operational deployment.

Unlike traditional collaborative programmes such as the European Defence Fund (EDF), AGILE is designed to provide more direct and flexible support to individual companies.

However, faster access to funding does not mean fewer legal obligations.

The agreed regulation introduces specific requirements concerning eligibility, corporate control, infrastructure, intellectual property and technology transfers. These conditions may determine not only whether a company receives funding, but also how it can commercialise its technology afterwards.

This article examines the legal framework, the opportunities for European and Ukrainian innovators, and the preparations companies should make ahead of the first calls in 2027.

1. What Has the EU Approved?

AGILE is intended to complement the existing European defence innovation framework, including the EDF, the EU Defence Innovation Scheme (EUDIS), the European Defence Industry Programme (EDIP) and relevant European Innovation Council instruments.

Its focus is on technologies capable of responding rapidly to identified defence needs.

The programme covers the development, testing and demonstration of innovative defence products, including the adaptation of civilian technologies for military applications.

Potential technological areas include:

  • Artificial intelligence and autonomous systems.

  • Unmanned aerial and ground platforms.

  • Counter-drone technologies.

  • Robotics and advanced sensors.

  • Cybersecurity and resilient communications.

  • Space-based and navigation technologies.

  • Other emerging and disruptive defence capabilities.

These areas are reflected in the regulation's objectives and recitals. The precise subjects eligible for funding will be determined through the implementing work programme and individual calls.

Key features of AGILE

€115 million budget. Article 4 establishes the programme's indicative financial envelope for 2027. Part of the budget may be used for implementation and administrative support, meaning the entire amount should not be treated as guaranteed grant funding.

Four-month time-to-grant objective. The Council identifies a significantly accelerated process compared with conventional EU defence funding instruments. The exact procedural timetable will depend on the work programme.

Operational relevance. Supported technologies are expected to become ready for use by defence end-users within approximately one to three years.

Mission-driven challenges. Member States will contribute to identifying capability needs, linking innovation funding more closely to operational requirements.

Testing and experimentation. AGILE provides for accelerated access, where available and appropriate, to relevant testing facilities and innovation-support mechanisms.

Industrial integration. Cooperation and matchmaking with established defence contractors should support the adoption and scaling of innovative solutions.

Potential funding of up to 100% of eligible costs. Article 14 permits this level of support, subject to the applicable financing arrangements.

The Commission may use simplified funding models, including lump sums and financing not linked directly to actual costs.

The programme is therefore more than another defence grant scheme. It represents an attempt to connect innovation, operational validation and industrial adoption through a faster funding mechanism.

Sources: Council of the EU, 12 October 2026; AGILE agreed legislative text, Articles 3–4, 8 and 14.

2. Legal Status: Adopted, but Not Yet in Force

The legislative process has reached its final institutional stage.

Date

Legislative milestone

25 March 2026

European Commission legislative proposal

15 July 2026

Political agreement between Parliament and Council

6 October 2026

European Parliament plenary approval

12 October 2026

Formal adoption by the Council

Next steps

Signature, publication in the Official Journal and entry into force

The agreed legislative text is available as PE-CONS 60/26, under procedure 2026/0078(COD).

As of 14 October 2026, formal publication in the Official Journal remains to be completed.

Article 25 of PE-CONS 60/26 provides for entry into force on the day following publication. However, the Council's press release refers to a 20-day period. The legally operative date should therefore be confirmed against the final Official Journal publication.

The European Commission expects the programme to become operational on 1 January 2027, with the first call for proposals anticipated in early 2027.

Practical consequence: companies should begin preparing now, but should not assume that a funding application can already be submitted or that the detailed eligibility and award conditions have been finalised.

The implementing work programme, adopted under Article 16, will determine the supported actions, challenges and further procedural requirements.

Sources: Council of the EU — adopted legislative text; European Commission — AGILE programme.

3. Who Can Apply? Eligibility Goes Beyond SME Status

One of AGILE's most important innovations is its focus on individual SMEs rather than exclusively on large research consortia.

However, being an SME established in the European Union is not sufficient on its own to establish eligibility.

Article 9 introduces several legal conditions.

Establishment and management

For the relevant funded actions, recipients must generally be established in an EU Member State or an associated third country.

Their executive management structures must also be located within the EU or an associated country.

The precise conditions depend on the category of action, and Article 9 contains specific exceptions.

Ownership and control

Recipients must not be controlled by a non-associated third country or a non-associated third-country entity.

This requires more than checking the company's registered shareholders.

A proper assessment should examine:

  • Ultimate beneficial ownership and the corporate control chain.

  • Shareholders' agreements and investor rights.

  • Voting arrangements and veto rights.

  • Board appointment and management powers.

  • Contractual arrangements capable of conferring decisive influence.

The critical legal issue is control, which may arise through mechanisms other than majority shareholding.

An EU-incorporated company may therefore face eligibility problems if its governance arrangements give a non-associated third-country entity decisive influence.

Infrastructure and resources

Article 9 also regulates the location of infrastructure, facilities, assets and resources used for funded activities.

As a general rule, the relevant resources must be located within the EU or an associated third country.

A limited exception may allow resources outside those territories to be used where suitable alternatives are unavailable and the other statutory conditions are met.

However, the costs of activities using such external resources are not eligible for AGILE support under that exception.

This distinction matters for companies relying on international engineering teams, specialised testing infrastructure or operational validation facilities.

It should be addressed before the proposed project structure is finalised.

Legal basis: AGILE agreed text, Article 9.

4. Ukraine: An Explicit Legal Route to Participation

Ukraine has a particularly important position within the AGILE framework.

Article 7(1)(b) expressly identifies Ukraine as a country that may participate through full or partial association with the programme, in accordance with the EU–Ukraine Association Agreement and the applicable arrangements.

Recital 21 further provides that Ukraine will not be required to make a financial contribution in order to become associated with AGILE.

This is a significant legislative development.

It creates a legal route for Ukrainian defence innovators to participate in a European funding instrument designed around rapid development, testing and operational deployment.

However, an important distinction must be maintained.

The possibility of association is established in the regulation. Automatic eligibility for every Ukrainian company from the first call is not.

Actual access will depend on the applicable association arrangements, the work programme and the eligibility conditions of the relevant funding procedure.

Opportunities for EU–Ukraine industrial cooperation

AGILE may create opportunities for European companies working with Ukrainian technology developers and testing partners.

Potential cooperation models include:

  • Ukrainian-developed technologies integrated into EU-based product development.

  • Joint engineering and industrial scale-up.

  • Defence technology validation under realistic operational conditions.

  • European manufacturing and supply-chain integration.

  • Licensing and commercialisation of Ukrainian innovations.

Each model requires separate analysis of ownership, control, eligible infrastructure, export authorisations and intellectual property rights.

In particular, testing in Ukraine should not automatically be assumed eligible for reimbursement under AGILE. Its treatment will depend on Ukraine's association status, the specific project arrangements and applicable programme rules.

For non-EU companies, Article 13 also allows the work programme to introduce exceptional inducement interventions, temporarily suspending certain establishment or management-location requirements.

These arrangements are conditional. Funding is provided only once the suspended criteria have been satisfied, and no pre-financing is available under that mechanism.

They should not be treated as a general exemption from eligibility requirements.

Legal basis: AGILE agreed text, Recitals 20–21 and Articles 7, 9 and 13.

5. Faster Grants, but Strict Verification

Speed is central to AGILE's design.

Article 12 allows the work programme to establish accelerated and simplified award procedures.

Under such procedures, an award decision may be based on applicants' self-declarations concerning eligibility and selection criteria, particularly corporate control, without requiring all supporting documentation during the preliminary evaluation.

This reduces the initial administrative burden.

It does not eliminate the underlying legal obligations.

The Commission must complete the final evaluation without undue delay. Under Article 12(3), payments may only be made after the final evaluation has been completed.

If the evaluation establishes that the recipient does not meet the required eligibility or selection criteria, the relevant legal commitment must be terminated.

The practical risk is therefore not simply that a company might be rejected. It may obtain a favourable preliminary decision but subsequently lose its funding commitment because its declarations cannot be substantiated.

Companies should prepare supporting evidence before submission, even where the application procedure initially relies on self-certification.

A pre-application legal review should cover corporate documents, control arrangements, management location, project infrastructure and any eligibility-specific declarations.

Legal basis: AGILE agreed text, Article 12.

6. Intellectual Property: Funding Does Not Mean Unrestricted Commercial Freedom

One of AGILE's most commercially significant provisions is Article 15, governing ownership of results.

The programme is intended to accelerate innovation, but it also protects European security and defence interests.

Restrictions on third-country control

Results generated through AGILE-supported actions must not be subject to control or restrictions imposed directly or indirectly by non-associated third countries or corresponding entities.

This expressly includes restrictions relating to technology transfer.

Transfers and exclusive licences

Article 15(4) introduces a specific regime for transfers of ownership or the grant of exclusive licences concerning programme-generated results to non-associated third countries or entities.

For transfers occurring within three years of the final payment, the regulation requires:

  • Prior notification to the European Commission.

  • Approval by the relevant Member State or associated-country authorities.

  • Compliance with conditions protecting EU and Member State security and defence interests.

Where a transfer or exclusive licence conflicts with the specified security interests or programme objectives, the support provided under AGILE must be reimbursed.

EU institutional access rights

Article 15(6) also provides for royalty-free access rights to results for EU institutions and relevant bodies, upon request, for defined policy and programme purposes.

Those rights are limited to non-commercial and non-competitive use and do not transfer ownership of the results.

Commercial consequences

These provisions should be addressed before the grant application, particularly where a company anticipates:

  • Investment from non-associated third-country investors.

  • Cross-border corporate restructuring.

  • Exclusive licensing arrangements.

  • Technology acquisition by an international defence prime.

  • International manufacturing or technology-transfer agreements.

Agreements covering background IP, newly developed results, source code, model weights, technical documentation and know-how should be structured with the applicable funding and transfer restrictions in mind.

A company may retain ownership of its technology while facing significant legal limitations on how that technology can be transferred or exclusively licensed.

This is not a secondary compliance issue. It can materially affect valuation, financing and future exit opportunities.

Legal basis: AGILE agreed text, Article 15.

7. Export Control and AI Regulation: Two Additional Layers

AGILE funding does not replace export-control authorisations or other regulatory requirements.

The applicable legal framework depends on the nature, classification, intended use and destination of the technology.

For defence and dual-use products, the principal EU instruments include:

Directive 2009/43/EC, concerning transfers of defence-related products within the EU.

Regulation (EU) 2021/821, establishing the EU export-control regime for dual-use items, software and technology.

National military export-control regimes and relevant sanctions rules may also apply.

A technology classified as a military item cannot simply be treated as a civilian dual-use product because it originated in the commercial market.

What about AI systems?

Regulation (EU) 2024/1689, the EU AI Act, contains an exclusion for AI systems developed or used exclusively for military, defence or national-security purposes, under the conditions established by Article 2.

However, this exclusion must be assessed against the system's actual intended purpose and circumstances of use.

An AI solution developed for both civilian and military applications may require a separate AI Act assessment for its non-excluded applications.

For companies transferring civilian AI, robotics or autonomous technologies into defence markets, regulatory classification should therefore be addressed at an early stage.

Sources: Directive 2009/43/EC; Regulation (EU) 2021/821; EU AI Act — Regulation (EU) 2024/1689.

8. From Innovation Funding to Defence Procurement

A grant is only valuable in the long term if the resulting technology can reach an operational customer.

AGILE expressly addresses this challenge.

Article 18 creates a link between certain procurement contracts for AGILE-supported defence products and the cooperative research and development exception under Article 13(c) of Directive 2009/81/EC.

Under the conditions defined by the regulation, qualifying contracts are treated as contracts awarded within the framework of a cooperative programme based on research and development.

This may facilitate the transition from publicly supported development to defence procurement.

However, it does not create an automatic right to a public contract.

Nor does it eliminate the need to address national procurement responsibilities, applicable authorisations, budget availability, security requirements and contractual negotiations.

The commercial opportunity lies in structuring an effective pathway from technical validation to acquisition and industrial deployment.

SMEs should therefore consider the following questions at the project-design stage:

Who is the intended military end-user?

What evidence will demonstrate operational readiness?

Can the product be manufactured and maintained at the required scale?

Who controls the necessary intellectual property?

What procurement and export-control requirements must be satisfied before delivery?

A credible acquisition and deployment strategy may be as important as the technological innovation itself.

Legal basis: AGILE agreed text, Article 18; Directive 2009/81/EC.

9. How Should Companies Prepare for the First Calls?

The initial AGILE implementation period is expected to begin in 2027.

Although the detailed work programme and first calls remain pending, companies can already prepare the legal and operational foundations of a credible application.

1. Establish eligibility.

Review SME status, corporate establishment, executive management, beneficial ownership and control arrangements. Identify potential restrictions involving non-associated third countries.

2. Assess the technology against defence needs.

Determine the product's maturity, operational relevance, technical differentiation and potential contribution to capability requirements identified by Member States.

3. Review the project structure.

Identify where development, testing, validation and production will take place. Assess infrastructure location, subcontracting arrangements and the eligibility of associated activities.

4. Protect intellectual property.

Document existing technology ownership and contractual rights. Establish arrangements for project results, licensing, future investment and cross-border technology transfers.

5. Establish the regulatory pathway.

Assess defence-product classification, dual-use export controls, applicable national authorisations, sanctions exposure, cybersecurity and, where relevant, AI Act obligations.

6. Prepare verification evidence.

Create an organised documentary record supporting eligibility declarations, ownership and control information, operational capabilities and compliance with the programme's conditions.

7. Monitor the implementation process.

The three immediate developments to follow are:

  • Publication of the adopted regulation in the Official Journal.

  • Adoption of the AGILE work programme.

  • Publication of the first funding calls and application documentation.

Early preparation can reduce the risk of discovering eligibility or commercialisation obstacles only after substantial resources have been committed to the application.

10. CORVUS AI Perspective: The Opportunity Is Broader Than Funding

AGILE represents an important development in European defence innovation policy.

Its central innovation is not the size of the budget, but the attempt to make EU support more responsive to the operational needs of defence organisations and the development cycles of smaller technology companies.

For European defence SMEs, it offers a potentially more accessible route to funding without the structural complexity of a large research consortium.

For civilian technology companies, it may provide an opportunity to adapt commercially developed solutions for defence applications.

For Ukrainian innovators, the regulation establishes an explicit legal route towards participation, potentially supporting deeper integration with European defence supply chains.

Yet the programme's opportunities are accompanied by significant legal conditions.

Eligibility, corporate control, infrastructure, intellectual property and technology-transfer arrangements should not be treated as administrative issues to resolve after an award.

They are central elements of project design and commercial strategy.

A successful AGILE project must be both technologically credible and legally executable.

CORVUS AI, a Netherlands-based legal and regulatory advisory practice, supports defence and dual-use companies with EU funding eligibility assessments, ownership and control reviews, intellectual property structuring, export-control analysis and cross-border project arrangements.

Our approach is to identify legal constraints early, translate them into defensible decisions and help companies move from regulatory readiness to project execution.

Disclaimer

This article has been prepared by CORVUS AI for general informational and educational purposes only. It is intended to make complex legal and regulatory developments easier to understand.

It does not constitute legal advice and does not create a professional adviser–client relationship. The information should not be relied upon as a substitute for advice based on the specific facts, circumstances and applicable law relevant to your organisation or project.

The article reflects our understanding of the law and regulatory framework as of the date of publication. Legislation, case law, regulatory guidance and administrative practice may subsequently change. While reasonable care has been taken in preparing this article, CORVUS AI does not warrant that the information is complete or remains current after the date of publication. We do not undertake to update this content.

To the fullest extent permitted by applicable law, CORVUS AI excludes liability for loss arising from reliance on this article. Nothing in this article constitutes an offer or solicitation to provide regulated legal services in any jurisdiction where doing so would be unlawful.

AI-assisted preparation: This article was prepared with the assistance of AI tools. Its legal analysis, conclusions and final text were subject to human review and editorial control and were reviewed and approved prior to publication by Oleksandr Sobovyi, Founder & CEO of CORVUS AI. CORVUS AI retains editorial responsibility for the published content.

For advice tailored to your organisation, project or specific circumstances, please contact CORVUS AI.

Complex law. Clear action.


Primary Legal Sources

  1. European Parliament and Council — AGILE agreed legislative text, PE-CONS 60/26, 6 October 2026. Principal legislative source, including Articles 7–9, 12–16, 18 and 25.

  2. Council of the European Union — Programme for Agile and Rapid Defence Innovation: Council Gives Final Green Light, 12 October 2026.

  3. European Commission, DG DEFIS — Programme for Agile and Rapid Defence Innovation.

  4. Directive 2009/81/EC — Defence and Security Procurement.

  5. Directive 2009/43/EC — Transfers of Defence-Related Products Within the EU.

  6. Regulation (EU) 2021/821 — EU Dual-Use Export Control.

  7. Regulation (EU) 2024/1689 — Artificial Intelligence Act.

Legal status and source review: 14 October 2026. This article analyses the agreed legislative text available on that date. The final Official Journal publication and subsequent implementing measures should be consulted for legally operative requirements.

© 2026 CORVUS AI | European Legal & Regulatory Intelligence

logo